This webinar will summarize the current bioanalytical landscape and its challenges, as well as discuss strategies to overcome them. Experts will describe how the stepwise approach for bioanalytical testing can be used to reduce risks and challenges present in biologics development. In addition, we will also discuss how the bioanalytical plans can be tailored to fit study needs at all project stages and its implications for CMC regulatory submission of biologic products.